Johnson & Johnson
(NYSE:JNJ)
$
256.98
-2.12 (-0.82%)
Market Cap: 618.61 Bil
Enterprise Value: 651.54 Bil
PE Ratio: 29.71
PB Ratio: 7.62
GF Score: 81/100 
Johnson & Johnson at Citi Global Healthcare Conference Transcript
Dec 03, 2025 / 04:15PM GMT
Release Date Price:
$205.33
(-0.04%)
Joanne Wuensch
Citibank - Moderator
I am Joanne Wuensch. I am the Medical Technology Analyst here at Citibank, and thrilled to have with us, Michael Bodner from Johnson & Johnson.
Michael Bodner
Johnson & Johnson - Group Chair of Electrophysiology and Neurovascular
Thank you.
Joanne Wuensch
Citibank - Moderator
Michael, thank you for joining us.
Michael Bodner
Johnson & Johnson - Group Chair of Electrophysiology and Neurovascular
It's a pleasure. Thank you for having me.
Questions & Answers
Joanne Wuensch;Michael Bodner
Citibank - Moderator;Johnson & Johnson - Group Chair of Electrophysiology
We do not get a lot of exposure to electrophysiology in -- from J&J. And so I would love to just sort of start off big picture -- how do you think about the health of the medical technology market and particularly as you think about it in terms of procedures and CapEx?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers